Pharmacy

A study found that most individuals diagnosed with focal epilepsy take over a year and more than one medication to be free of seizures.  The study, led by researchers from the U.S. and Australia and published in JAMA Neurology, followed…

The FDA has approved Pfizer and BioNTech’s updated COVID-19 vaccine for adults 65 and older along with individuals ages 5-64 who are at increased risk of severe COVID-19.  The new formulation targets several SARS-CoV-2 sublineages, aligning with the FDA guidance…

Normally by this time of year as fall approaches, the FDA has approved new formulas for COVID-19 shots and CDC recommendations on who should receive them have been finalized.  As this year’s respiratory virus season kicks into gear and COVID…

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their most recent value-driven wins. The 5 executives featured in this article are all speaking at the Becker’s Healthcare Fall Chief Pharmacy Officer Summit, from Nov.…

Three pharmaceutical groups filed federal lawsuits against North Dakota’s recently passed 340B law, the North Dakota Monitor reported Aug. 26.  House Bill 1473 was signed into law by Gov. Kelly Armstrong earlier this year, making it a class B misdemeanor…

Here are five new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. 

Pfizer is laying off 100 workers in Bothell, Wash., according to a WARN notice filed Aug. 25.  The Bothell, Wash.-based facility previously served as the headquarters for Seagen, a cancer therapeutics company Pfizer acquired for $43 billion in 2023. The…

Labels for GLP-1 medications, like Ozempic and Mounjaro, might see more approved uses as researchers study the drugs' effects on sleep apnea, dementia and other health issues. Meanwhile, oncologists are looking at a GLP-1 role in cancer care.

Eli Lilly’s oral GLP-1, orforglipron, led to significant weight loss and blood sugar reductions in a late-stage clinical trial.  In the phase 3 study, adults with obesity, were overweight and with Type 2 diabetes lost an average of 10.5% of…

Eversana, a pharmaceutical distributor and marketing company, has acquired a software company with plans to disrupt “the industry’s misaligned incentives and fragmented patient experiences,” according to an Aug. 26 news release.  The acquired firm, Waltz Health, offers prescription drug-pricing technology…